Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,335.30 -19.12 -0.12%
S&P 500 1,666.29 -1.18 -0.07%
Nasdaq 3,496.43 -2.53 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,803.52 -20.98 -0.74%
FTSE 100 6,759.26 +3.63 0.05%
DAX 8,416.15 -39.68 -0.47%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,180.06 -28.98 -0.56%
  • Exchange: ASE
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Audeo Oncology Inc

0602211D:AU

Pending Listing

Audeo Oncology Inc (0602211D:AU) is pending listing


Company Profile

Audeo Oncology, Inc. is a late stage biopharmaceutical company primarily focused on utilizing Hyaluronic Acid Chemotransport Technology, or HyACT, to target cancer drugs preferentially to tumor cells to enhance drug activity.

Advertisement
sec ||= nil